Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03425682 · ClinicalTrials.gov registry record
ViBone in Cervical and Lumbar Spine Fusion
A clinical trial, sponsored by Elutia.
- Completed
- Registry status
- 118
- Enrollment target
NCT03425682: Completed study, sponsored by Elutia.
NCT03425682 is a clinical trial that has completed, run by Elutia. The registered enrollment target is 118 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03425682 has completed, sponsored by Elutia.
- COMPLETED
- Registry status
- 118 participants
- Enrollment target
Study Summary
Assess clinical and radiographic outcomes in patients who undergo 1-3 level anterior cervical discectomy fusion (ACDF) or lumbar interbody fusion (TLIF, PLIF, ALIF, or LLIF) using ViBone.
Primary Outcome
Successful fusion rates for ViBone as defined by Grade I or II level of fusion on the Bridwell Interbody Grading Scale (below). The percentages below show at 12 months the amount of fusion per level for cervical and lumbar fusion procedures utilizing ViBone. Grade I: Fused with remodeling and trabeculae present. Grade II: Graft intact, not fully remodeled and incorporated, but no lucency present. Grade III: Graft intact, potential lucency present at top and bottom of graft. Grade IV: Fusion ab
Interventions
- OTHER ViBone
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 118 participants |
| Start Date | 2018-05-14 |
| Est. Completion | 2021-06-30 |
What the finished NCT03425682 record still lists
NCT03425682 is an observational study that tracks outcomes without assigning an intervention. The registered 118 participants enrollment target is mid-sized for trials with a published cap.
The record links to 0 conditions, and to 1 intervention - of which ViBone is the first listed.
NCT03425682 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT03425682 about?
NCT03425682 is a clinical study titled "ViBone in Cervical and Lumbar Spine Fusion". Assess clinical and radiographic outcomes in patients who undergo 1-3 level anterior cervical discectomy fusion (ACDF) or lumbar interbody fusion (TLIF, PLIF, ALIF, or LLIF) using ViBone.
What is the current status of trial NCT03425682?
This trial is currently completed. The enrollment target is 118 participants. The study started on 2018-05-14. Estimated completion is 2021-06-30.
What interventions are being tested in trial NCT03425682?
The interventions under investigation include: ViBone (OTHER).
Who is sponsoring clinical trial NCT03425682?
This trial is sponsored by Elutia, which has 10 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03821623 · 118 participants · Phase 2
Nicotinamide Riboside for Treating Elevated Systolic Blood Pressure and Arterial Stiffness in Middle-aged and Older Adults
- NCT04040959 · 118 participants · Phase 2
Nicotinamide Riboside Supplementation for Treating Arterial Stiffness and Elevated Systolic Blood Pressure in Patients With Moderate to Severe CKD
- NCT04696029 · 118 participants · Phase 2
DFMO as Maintenance Therapy for Molecular High/Very High Risk and Relapsed Medulloblastoma
- NCT05223192 · 118 participants · NA
The Effects of Entrainment on Respiratory Stability and Cerebral Oxygenation in Preterm Infants
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI